The ventricular restoration system is different from the conventional surgical reconstructive procedure and is a less invasive method for heart failure patients. Cardiovascular diseases are on a consistent rise in countries across the globe. Numerous advancements have been made in the cardiac field to provide better care. Ambulatory surgical centers and hospitals provide these restoration systems. Several factors such as changing lifestyle, the rise in obesity, technological novelty, increase in rates of heart-related diseases, rise in aged population, and surge in funding in the healthcare sector are driving the market forward.
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the ventricular restoration systems market.
Top Impacting Factors
- Rise in cases of cardiac diseases mainly left ventricle aneurysm, growth in medical tourism, increasing demand for innovative products, increase in demand for minimally invasive procedures & advanced cardiovascular treatment, are the factors that drive the growth of ventricular restoration systems market.
- In addition, increase in healthcare expenditure; availability of skilled professionals; rise in R&D activities to improve quality of medical devices with technological advancements, the launch of novel developed devices in the market; are some factors, which boost the market growth for ventricular restoration systems.
- However, strict regulations for approval, high cost involved in the ventricular restoration systems, lack of knowledge for proper handling of the device, and associated complications hinder the ventricular restoration systems market growth.
Ventricular Restoration Systems Market Trends
New product launches to flourish the market
In November 2020, Abbott Laboratories launched a new clip delivery system for minimally invasive treatment of leaky mitral valves. Leaky mitral valves repaired by these clips without open-heart surgery, delivered through any vein in the leg.
In February 2020, Xeltis AG showcased RESTOREXTM technology at the Spirit of Berne Conference in Switzerland. It permits patients needing cardiovascular replacement to produce new living blood vessels or heart valves made from their own tissue
Key Benefits of the Report
- This study presents the analytical depiction of the ventricular restoration systems industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the ventricular restoration systems market share.
- The current market is quantitatively analyzed to highlight the ventricular restoration systems market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the ventricular restoration systems market.
- The report provides a detailed ventricular restoration systems market analysis based on competitive intensity and how the competition will take shape in coming years
Questions answered in the ventricular restoration systems Report
- Which are the leading players active in the ventricular restoration systems market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the ventricular restoration systems market?
- What future projections would help in taking further strategic steps?
- What is "Ventricular restoration systems "?
- What is "Ventricular restoration systems" Market prediction in the future?
- Who are the leading global players in the "Ventricular restoration systems" Market?
- What are the current trends and predicted trends?
- What are the key benefits of the "Ventricular restoration systems" Market report?
Ventricular Restoration Systems Market Report Highlights
| Aspects | Details |
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Xeltis AG, Bioventrix Inc., Abbott, ON-X LIFE TECHNOLOGIES INC, Edwards Lifesciences Corp., Medtronic, Valtech, CardioKinetics Inc, CryoLife Inc., Neochord Inc. |
Loading Table Of Content...
